Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model
Anticholinergics, and drugs with anticholinergic properties, are widely and frequently prescribed, especially to the elderly. It is well known that these drugs decrease cognitive function and increase the risk of dementia. Although the mechanism of anticholinergic drug-induced cognitive impairment h...
Main Authors: | Yasumasa Yoshiyama, Ayako Kojima, Kimiko Itoh, Tomoyuki Uchiyama, Kimihito Arai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096999611100283X |
Similar Items
-
Glial contributions to neurodegeneration in tauopathies
by: Cheryl E. G. Leyns, et al.
Published: (2017-06-01) -
Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: Implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression
by: Shunsuke Koga, et al.
Published: (2014-11-01) -
Progressive neurodegeneration in C. elegans model of tauopathy
by: Tomohiro Miyasaka, et al.
Published: (2005-11-01) -
Association between Anticholinergic Burden and Constipation: A Systematic Review
by: Héctor Rodríguez-Ramallo, et al.
Published: (2021-05-01) -
An anticholinergic burden score for German prescribers: score development
by: Esther Katharina Kiesel, et al.
Published: (2018-10-01)